Sinovac Biotech, Accounts Payable

Sinovac Biotech, (SVA) currently reports a accounts payable of $16M as of December 2025. Use the charts on this page to explore Sinovac Biotech,'s accounts payable history and peer comparisons.

Sinovac Biotech, reported $16M in accounts payable as of December 2025. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sinovac Biotech,, and consider following SVA for alerts when major investors trade the stock.

Sinovac Biotech, is classified in the Healthcare sector. On accounts payable, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SVA with unrelated industries.